AFM-14

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAFM-14

Drug Alias Nameanti-GPIIb/IIIa Fab antibody (Affimed)AFM-14

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment

Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonistsCoagulation factor inhibitors

TargetsIntegrin alpha-IIb/beta-3Coagulation factor

Therapy Area/IndicationsThrombosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAffimed Nv

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAffimed Nv

Active IndicationsN/A

Inactive IndicationsThrombosis

Other Information

ATC CodeN/A